📰 The The Observer reports today on why gaining access to our volunteers’ GP data would transform research into the causes and treatment of disease ow.ly/7lkI50SGHkI

- UK Biobank has received an additional £16m in backing from Amazon Web Services & UK Government to support essential research to develop new diagnostics, treatments and cures for devastating diseases like Parkinson’s, dementia and cancer 🙌 bit.ly/3LAHGL4 bit.ly/3LAHGL4

“This research is helping us develop the treatments that will improve & hopefully prolong all our lives." Peter Kyle visits UK Biobank as the government & @AWScloud deliver a joint £16m funding to improve data storage that will help researchers deliver medical breakthroughs.

UK expensive visas - latest evidence: - Cancer Research UK is expecting to spend £700k on visa costs each year - the equivalent cost of 17 new CRUK PhD students - Cambridge cancer institute being outcompeted for specialists by institutes in Germany, due to costs

UK visa costs are some of the highest in the world. Reviewing and addressing these high costs is a necessary step in attracting and retaining international scientific talent.

Great to welcome Department for Science, Innovation and Technology and Lord Vallance to our Manchester campus yesterday to meet some of the most impactful genomics and diagnostics businesses in the region The University of Manchester MFT Research and Innovation Health Innovation Manchester QIAGEN Yourgene Health

Great to be working with Royal Institution on this one. Join us..its going to be a fun day at Alderley Park!

Following this week's visit by Patrick Vallance to our Manchester Science Park and Citylabs campuses, Kath Mackay reflects on the arrival of a new Department for Science, Innovation and Technology as a chance to invest into triple helix partnerships in Forbes. 📖 bit.ly/46mu7Zf bit.ly/46mu7Zf

“A centre of gravity to the Health Secretary’s mission, not only to transform and invest in the NHS, but to champion & harness the spirit of this immensely innovative nation” Birmingham Health Innovation Campus perfectly summed up in Al Carns’ maiden speech 👏 Bruntwood SciTech

In his recent blog for Medicines Discovery Catapult, our Head of Laboratory Services Gareth Hampton reviews the key considerations for businesses in search of lab space: ➡️ bit.ly/3WI7206 🔎 Looking for lab space? See how we can help: bit.ly/4cQAuGu bit.ly/3WI7206

'Gene therapy would mean a lot to me — it would be a life-changing treatment.' Kirthana has thalassaemia and could be one of the the first people in the world to benefit from a gene-editing treatment that could cure her blood disorder. england.nhs.uk/2024/08/gene-e…

Patients in the U.K. with transfusion-dependent beta-thalassemia will have access to Vertex Pharmaceuticals’s gene editing therapy Casgevy, thanks to an agreement with the NHS England on the price. hubs.li/Q02KyZ2G0 #pharma #biospace

ScaleUp Institute with the London Stock Exchange and the Greater Manchester Ecosystem, including Manchester Digital and The Greater Manchester Business Growth Hub, are hosting a ScaleUp Summit 📆 10th Sept 24 at Manchester Technology Centre. buff.ly/4dHNAGj #scaleupbritain

Exclusive: Some of London’s leading universities - including UCL and King’s College London - are in talks to form a new £500m investment vehicle called London Atrium to back companies founded by academics in sectors such as healthcare and cybersecurity. news.sky.com/story/london-u…

Delighted to be working with Lifted Ventures to bring our Female Founders Incubator to Alderley Park. Ready to support the next generation of tech business. Apply below 👇

A tough but important read. Bravo NHSA and Health Equity North highlighting this.

Congratulations to Scantox and all at Gentronix Ltd

This was a brilliant event hosted by Department for Science, Innovation and Technology and attended by our Chief Scientific Officer Dr. Kath Mackay bringing together various spokespeople and industry leaders across science and tech 👏

💡 Working in partnership to deliver personalised healthcare solutions at MFT NHS, supported by Bruntwood SciTech. Prof Bill Newman, Consultant in Genomic Medicine explains how we are working with APIS Assay Technologies as part of the Devote programme to develop a pharmacogenetics passport.

New forecasts reveal that without urgent action, antimicrobial resistance will kill 1.9 million a year by 2050. #UNGA79 is a critical opportunity for global leaders and policymakers to tackle the threat. Estimates in the latest GRAM report will be a key tool for them ⤵️  [1/3]